Cite
BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma.
MLA
Yaodong He, et al. “BANF1 Is a Novel Prognostic Biomarker Linked to Immune Infiltration in Head and Neck Squamous Cell Carcinoma.” Frontiers in Immunology, Oct. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1465348.
APA
Yaodong He, Huan Li, Jing Li, Junhong Huang, Rong Liu, Yanbing Yao, Yating Hu, Xinjie Yang, & Jianhua Wei. (2024). BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma. Frontiers in Immunology, 1–16. https://doi.org/10.3389/fimmu.2024.1465348
Chicago
Yaodong He, Huan Li, Jing Li, Junhong Huang, Rong Liu, Yanbing Yao, Yating Hu, Xinjie Yang, and Jianhua Wei. 2024. “BANF1 Is a Novel Prognostic Biomarker Linked to Immune Infiltration in Head and Neck Squamous Cell Carcinoma.” Frontiers in Immunology, October, 1–16. doi:10.3389/fimmu.2024.1465348.